Rheumatoid Arthritis Treatment: What Works, What Doesn’t, and Why

Rheumatoid Arthritis (RA) is a serious, systemic autoimmune disease. Rheumatoid arthritis is treatable, but treatment has to target the actual disease process, not just mask symptoms. This page explains what really works for RA, how treatments work, and why adequate treatment matters so much.

Quick Overview: How RA Is Treated

RA treatment aims to:

• Suppress the immune-driven inflammation attacking your joints
• Prevent irreversible joint damage
• Reduce pain and stiffness
• Preserve your function and quality of life

The most effective treatments work by modifying the disease itself, by reducing inflammation. 

The Core Principle: Treat the Inflammation

RA pain improves when inflammation is controlled. It’s that straightforward.

Effective treatment means:

• Reducing synovitis (the inflammation in your joint lining)
• Suppressing cytokines, inflammatory chemicals like TNF and IL-6 that drive the disease
• Preventing erosions and structural damage to cartilage and bone

The goal isn’t just feeling better today, it’s stopping the inflammatory process that causes permanent damage to your joints and, if left unchecked, can affect your heart, lungs, and other organs.

Internal link: Inflammation in Rheumatoid Arthritis

DMARDs: The Foundation of RA Treatment

DMARDs (Disease-Modifying Anti-Rheumatic Drugs) are first-line treatment for RA. Methotrexate is the gold standard treatment, and often the first medication tried.  Current guidelines emphasize that methotrexate should be part of the first treatment strategy PubMed Central for most patients with active RA.

All DMARD medications work by modulating your immune system to reduce inflammation and prevent joint damage. Common conventional DMARDs include:

• Methotrexate
• Sulfasalazine
• Hydroxychloroquine (Plaquenil)
• Leflunomide

Internal link: /treatment/dmards/

What you need to know about DMARDs:

• They may take weeks and up to three months to reach full effect (not instant relief)
• They’re used long-term to control disease
• They require regular blood test monitoring
• They’re not painkillers—they actually change the course of your disease

The patience required while waiting for DMARDs to work can be brutal, but they’re your best shot at preventing permanent joint damage.

Methotrexate: The Anchor Drug

Methotrexate is often the first medication prescribed because it:

• has the strongest evidence base
• reduces inflammation effectively
• improves outcomes when started early
• enhances the effectiveness of biologics

Many people fear methotrexate, but this is largely due to misinformation. When monitored properly, it is safe and effective for most patients.

Biologic Therapies

Biologics are targeted therapies used when conventional DMARDs aren’t enough. Evidence-based guidelines recommend biologics as second-line therapy for patients for whom conventional DMARDs have failed The Rheumatologist.

These medications block specific immune pathways that drive inflammation:

• TNF inhibitors (like adalimumab, etanercept, infliximab)—block tumor necrosis factor
• IL-6 inhibitors (like tocilizumab, sarilumab)—block interleukin-6
• B-cell depleting agents (like rituximab)—target B-cells
• T-cell co-stimulation modulators (like abatacept)

When appropriate, biologics can dramatically reduce disease activity and prevent the frequent flares that make life with RA so unpredictable.

JAK Inhibitors

JAK inhibitors are oral medications that interfere with inflammatory signaling pathways inside cells. These novel immunomodulating drugs have revolutionized RA management by targeting specific intracellular signaling pathways involved in disease pathogenesis The Rheumatologist.

They’re typically used for:

• Moderate to severe RA
• Patients who haven’t responded well to other treatments

JAK inhibitors act relatively quickly compared to conventional DMARDs and can be highly effective, though they require careful monitoring for potential side effects.

Internal link (future): /treatment/jak-inhibitors/

Corticosteroids (Prednisone / Prednisolone)

Steroids reduce inflammation rapidly and can be incredibly helpful for:

• Acute flares
• Bridging the gap while waiting for DMARDs to kick in
• Short-term disease control

But here’s the problem: Steroids aren’t safe for long-term use. They cause significant side effects including bone loss, weight gain, increased infection risk, and metabolic problems. More importantly, they can mask inadequate disease control—you might feel better temporarily while joint damage continues underneath.

Steroids should be a temporary solution, not your main long-term RA treatment.

Internal link: RA Flares

NSAIDs and Pain Relief

NSAIDs (like ibuprofen, naproxen, celecoxib) help with:

• Pain reduction
• Decreasing swelling
• Making daily life more manageable

What they don’t do: Prevent joint damage or modify disease progression.

NSAIDs are supportive—they help you function while your disease-modifying drugs do the real work. Relying on pain relief alone without controlling inflammation is a path to progressive disability.

Treat-to-Target: What It Means (and What It Often Becomes)

Treat-to-target aims for:

• remission
• or low disease activity

This is best practice.

Treat-to-Target: When “Controlled” Disease Isn’t Actually Controlled

TrTreat-to-target rheumatology care aims for remission or low disease activity PubMed Central—an evidence-based standard that should guide treatment decisions.

But there’s a dangerous gap between theory and practice.

Some patients with persistent pain, fatigue, and functional decline are told their inflammatory disease is “well-controlled” based solely on normalized bloodwork. When symptoms don’t align with lab values, rheumatologists may diagnose fibromyalgia and scale back disease-modifying treatments.

This can leave real inflammatory disease undertreated.

What happens when inflammatory symptoms are misclassified:

• Treatment targets get quietly lowered instead of intensified
• Ongoing joint damage or systemic inflammation continues unchecked
• Pain is dismissed as “central sensitization” rather than investigated as active disease
• Access to biologics or advanced therapies is denied or delayed

If your symptoms persist despite “good numbers,” push back. Request imaging, ask about subclinical inflammation, and advocate for treat-to-target that actually targets your symptoms—not just your labs. Fibromyalgia is real, but it shouldn’t become a default diagnosis that stops your rheumatologist from treating inflammatory disease that’s still active.

Why RA Is So Often Undertreated

Common reasons include:

• Delayed diagnosis (it takes an average of 6-12 months from symptom onset to diagnosis)
• Underestimation of patient-reported pain
• Gender bias in pain assessment
• “Normal” blood tests despite active disease (seronegative RA is real)
• Mislabeling inflammatory pain as fibromyalgia or “central sensitization”
• Patient fear of medications based on online misinformation
• Physician hesitancy to escalate treatment

Undertreatment leads to:

• More frequent flares
• Progressive joint damage
• Increasing disability

Avoidable suffering

Treatment Is Not One-Size-Fits-All

RA treatment needs to be individualized based on:

• Disease severity and activity level
• Serostatus (whether you’re RF or anti-CCP positive)
• Comorbidities and overlapping conditions
• Your response to medications
• Side effect tolerance

Some people require aggressive combination therapy or biologics early. Others maintain good control for years on a single DMARD. There’s no universal “right” approach – what matters is achieving adequate disease control for your specific situation.ments early.  Others do well for years on one medication.  Everyone is different and everyone’s RA is different.   There is little value in comparing.

Living Well With Treatment

Effective treatment can:

• reduce pain
• reduce flares
• reduce fatigue
• improve energy
• preserve independence
• allow exercise and participation in life

Treatment should support living…not just lab results.

The Bottom Line

Rheumatoid Arthritis is treatable,  but only when inflammation is taken seriously.

If pain persists, flares continue, or function declines, treatment is not adequate.

You deserve care that targets the disease and it’s important to advocate for yourself, if you feel you are not being listened to, or your pain is not being taken seriously.

FAQ